Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum YM BioSciences Inc YMI

NYSEAM:YMI - Post Discussion

YM BioSciences Inc > Will gap fill?
View:
Post by CGPlanner on Aug 25, 2009 10:58pm

Will gap fill?

That is the question, however, if it breaks $2.10 it may be free to go to $3 because the fundamentals are now strong.  Bio-tech stocks are known to go straight up and not return, and of course straight down and fizzle. The fundamentals once again are very strong.  Do your own DD.  I do agree that chasing a stock is not the best approach either.  The 20 day MAVG is below the 50 day MAVG indicating upward movement.  THere may also be some retracement as there was throughout the day and then higher highs.  I guess we will all see in time.   The long position on this is very postive and the question we will all entertain is "Will there be a buy out?"
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities